COPPELL, Texas--(BUSINESS WIRE)--Mar. 10, 2016--
Mannatech,
Incorporated (NASDAQ: MTEX),
the founder of the M5MSM
(Mission 5 MillionSM) Foundation, the pioneer of
Glyconutrition and the global innovator of naturally sourced supplements
based on Real
Food Technology® solutions, is showing strong early
returns from its recent, highly anticipated opening of operations in
Colombia.
“We’ve had an amazing reaction to our entry into Colombia,” said
Mannatech’s CEO and President, Alfredo “Al” Bala. “We saw people, eager
to join us, line up around the block the day we opened up our office in
Bogotá. We also experienced tremendous excitement at our openings in
Medellin and Barranquilla. It was a wonderful feeling to see such
enthusiasm, and we are thrilled to be able to deliver the highest
quality health and wellness products to this incredible country.”
Mannatech opened its offices in Colombia on February 13, and had
record-setting numbers of new independent sales Associates join. With
its grand opening events set for April 26-30, in Medellin, Barranquilla
and Bogotá, Mannatech is looking to make an even bigger splash among the
people of Colombia.
“It’s clear that many people in Colombia desire the high quality and
clinically tested products that Mannatech offers to help sustain the
health and wellness of themselves and their families,” Bala said.
“Colombia is extremely important to Mannatech, and we’re committed to
providing the best products on the market as well as an outstanding
opportunity for entrepreneurs who are seeking ways to build a long-term,
successful business.”
To coincide with the new launch of Mannatech Colombia’s operations, the
company has launched four new incentives to help Associates in Colombia
get their business off the ground and running. These incentives
encourage positive business-building skills and offer product and cash
prizes. In order to earn the incentive, new Associates must sign-up
through Mannatech’s Colombia office.
Mannatech offers a unique set of health and wellness products based on
its pioneering development of Glyconutritional technology.
Glyconutrition supports communication on a cellular level and has shown
to support the body’s immune system and other important functions for
overall health.*
Mannatech’s core technology has undergone 17 human clinical trials that
have been published, 12 of which were double-blind, placebo-controlled
studies — the gold standard for product validation. Mannatech holds more
than 100 patents in major global markets for certain product technology,
including its Glyconutritional technology.
Mannatech’s quality standards are among the highest in the industry,
with many of its core products receiving certification from NSF
International. Additionally, Mannatech’s quality assurance program
complies with the U.S. Food and Drug Administration’s (FDA) Good
Manufacturing Practices for Dietary Supplements, which impacts product
development, manufacturing, evaluation and distribution.
Mannatech Colombia’s team includes Juan Carlos Arias, General Manager of
Colombia; Olga Zamudio, Sales Director of Hispanic Markets; and Emma
Avila-Rocha, International Operations Manager.
Mannatech’s Bogotá office is located at Carrera 45 No. 108-27, Torre 2,
Oficina 1206, Centro Empresarial Paralelo 108. Follow developments at
Mannatech Colombia, its programs and incentives via its Facebook
page.
For more information about Mannatech and its products, go to: www.mannatech.com.
*These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat, cure
or prevent any disease.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing childhood nutrition where it is needed
around the world. Mannatech’s proprietary products are available through
independent sales associates around the globe including North
America/South America (United States, Canada, Colombia and Mexico),
Asia/Pacific (Australia, New Zealand, Japan, Taiwan, Singapore, the
Republic of Korea, and Hong Kong), and EMEA (Austria, Denmark, Germany,
Norway, Sweden, the Netherlands, the United Kingdom, Estonia, Finland,
the Republic of Ireland, Czech Republic, South Africa, and the Republic
of Namibia). For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160310005041/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Kalyn Ballard, 972-471-7245
pr@mannatech.com